合成ホルモン市場：製品、投与経路、用途、エンドユーザー別-2025～2030年の世界予測

合成ホルモン市場は、2023年に8億9,920万米ドルと評価され、2024年には10億2,443万米ドルに達すると予測され、CAGR 14.41%で成長し、2030年には23億777万米ドルに達すると予測されています。

合成ホルモンは、主に医療と農業セグメントで様々な用途に使用される人工的に作成されたホルモンです。これらのホルモンは天然ホルモンを模倣するように設計されており、ホルモン関連の欠乏症や疾患の治療の鍵となります。合成ホルモンの必要性は、ホルモンバランスの乱れ、更年期症状、避妊の必要性、成長障害などの状態を管理・治療する必要性から生じます。農業においては、家畜の成長率や生産性を高めるために極めて重要です。主要用途は、ホルモン治療や避妊に不可欠な成分を構成する医薬品や獣医療です。最終用途は主に医療施設、製薬会社、農業セグメントです。

合成ホルモン市場は、ホルモン疾患に対する認識の高まり、バイオテクノロジーの進歩、ホルモン療法を必要とする高齢化人口の増加によって牽引されています。個人のウェルネスや予防医療に対する需要の高まりが、市場の成長をさらに後押ししています。バイオアイデンティカル・ホルモンの開発や、患者のコンプライアンスと有効性の向上を約束する経皮パッチや埋め込み型デバイスなどの新しい送達システムの探求に新たな機会が存在します。さらに、個別化医療は、個々の患者のニーズに合わせてホルモン治療を調整する展望を記載しています。

しかしながら、市場は規制上のハードル、使用に関する倫理的懸念、潜在的副作用などの制約に直面しており、これが成長を抑制する可能性があります。さらに、合成医薬品に対する社会的不信と天然代替品への嗜好の高まりが大きな課題となっています。市場関係者は、消費者の懸念に対処するため、臨床研究の透明性と安全性を優先する必要があります。

市場の潜在力を活用するためには、より安全で効果的な送達方法の革新と、持続可能で倫理的な生産プロセスの開発のための研究開発に重点を置くべきです。新規治療領域での使用拡大に向けてさらに調査を進めれば、新たな成長の道を開くことができます。地域によって異なる規制状況を理解することも有益です。合成ホルモン市場の性質はダイナミックであり、技術の進歩や消費者の嗜好の変化に絶えず適応しているため、新たな動向に常に注意を払う必要があります。

市場力学：急速に進化する合成ホルモン市場の主要市場洞察を公開

合成ホルモン市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネス機会の獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 人口におけるホルモンバランスの乱れの発生率の急増
  • 甲状腺関連疾患の有病率の上昇と医療費の増加
  • バイオアイデンティカルホルモンに関する消費者の意識の急上昇
• 市場抑制要因
  • ホルモン補充療法に伴う高コスト
• 市場機会
  • メーカーによる新製品の研究開発の増加
  • 月経不順の増加
• 市場課題
  • ホルモン剤に関連する特定の副作用

ポーターのファイブフォース：合成ホルモン市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォースフレームワークは、企業の競合を評価し、戦略的機会を探るための明確な手法を記載しています。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これら洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：合成ホルモン市場における外部からの影響の把握

外部マクロ環境要因は、合成ホルモン市場の業績力学を形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を記載しています。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析：合成ホルモン市場における競合情勢の把握

合成ホルモン市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、セグメント化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックス：合成ホルモン市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、合成ホルモン市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨：合成ホルモン市場における成功への道筋を描く

合成ホルモン市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネス機会を活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目セグメントを網羅した市場の包括的な分析を提供しています。

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力を評価します。

2.市場の開拓度：新興市場における成長機会を特定し、既存セグメントにおける拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを記載しています。

3.市場の多様化：最近の製品発売、未開拓の地域、産業の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発とイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています。

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、地域はどこか？

3.市場を形成する主要技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 人口におけるホルモン不均衡の発生率の急増
    • 甲状腺関連疾患の罹患率の上昇と医療費の増加
    • バイオアイデンティカルホルモンに関する消費者の意識の急速な高まり
  • 抑制要因
    • ホルモン補充療法には高額な費用がかかる
  • 機会
    • メーカーによる新製品の研究開発の増加
    • 月経不順の発生率上昇
  • 課題
    • ホルモンに関連する特定の副作用
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 法律
  • 環境

第6章 合成ホルモン市場：製品別

• イントロダクション
• アミノ酸誘導体
• ペプチドホルモン
• ステロイドホルモン

第7章 合成ホルモン市場：投与経路別

• イントロダクション
• 静脈内
• 鼻腔
• 経口
• 坐薬
• 局所

第8章 合成ホルモン市場：用途別

• イントロダクション
• 成長ホルモン欠乏症
• 男性性腺機能低下症
• 閉経
• 甲状腺ホルモン欠乏症

第9章 合成ホルモン市場：エンドユーザー別

• イントロダクション
• 病院薬局
• オンライン薬局
• 小売薬局

第10章 南北アメリカの合成ホルモン市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋の合成ホルモン市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの合成ホルモン市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• American Regent, Inc. by Daiichi Sankyo Group Company
• BIOTE MEDICAL, LLC.
• CSBio
• Endo Pharmaceuticals Inc.
• Ferring International Center S.A.
• Lyndra Therapeutics
• Pfizer Inc.
• Slayback Pharma LLC

LIST OF FIGURES

• FIGURE 1. SYNTHETIC HORMONES MARKET RESEARCH PROCESS
• FIGURE 2. SYNTHETIC HORMONES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL SYNTHETIC HORMONES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES SYNTHETIC HORMONES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES SYNTHETIC HORMONES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC SYNTHETIC HORMONES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC SYNTHETIC HORMONES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC HORMONES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC HORMONES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. SYNTHETIC HORMONES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. SYNTHETIC HORMONES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. SYNTHETIC HORMONES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL SYNTHETIC HORMONES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. SYNTHETIC HORMONES MARKET DYNAMICS
• TABLE 7. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY AMINO ACID DERIVATIVES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY PEPTIDE HORMONE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY STEROID HORMONES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY NASAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY SUPPOSITORY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY GROWTH HORMONE DEFICIENCY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY MALE HYPOGONADISM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY MENOPAUSE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY THYROID HORMONE DEFICIENCY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 31. ARGENTINA SYNTHETIC HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA SYNTHETIC HORMONES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA SYNTHETIC HORMONES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 35. BRAZIL SYNTHETIC HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 36. BRAZIL SYNTHETIC HORMONES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 37. BRAZIL SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 38. BRAZIL SYNTHETIC HORMONES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 39. CANADA SYNTHETIC HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 40. CANADA SYNTHETIC HORMONES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 41. CANADA SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 42. CANADA SYNTHETIC HORMONES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 43. MEXICO SYNTHETIC HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 44. MEXICO SYNTHETIC HORMONES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 45. MEXICO SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 46. MEXICO SYNTHETIC HORMONES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 47. UNITED STATES SYNTHETIC HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 48. UNITED STATES SYNTHETIC HORMONES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 49. UNITED STATES SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 50. UNITED STATES SYNTHETIC HORMONES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 51. UNITED STATES SYNTHETIC HORMONES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 52. ASIA-PACIFIC SYNTHETIC HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 53. ASIA-PACIFIC SYNTHETIC HORMONES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 54. ASIA-PACIFIC SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 55. ASIA-PACIFIC SYNTHETIC HORMONES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 56. ASIA-PACIFIC SYNTHETIC HORMONES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 57. AUSTRALIA SYNTHETIC HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 58. AUSTRALIA SYNTHETIC HORMONES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 59. AUSTRALIA SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 60. AUSTRALIA SYNTHETIC HORMONES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 61. CHINA SYNTHETIC HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 62. CHINA SYNTHETIC HORMONES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 63. CHINA SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 64. CHINA SYNTHETIC HORMONES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 65. INDIA SYNTHETIC HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 66. INDIA SYNTHETIC HORMONES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 67. INDIA SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 68. INDIA SYNTHETIC HORMONES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 69. INDONESIA SYNTHETIC HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 70. INDONESIA SYNTHETIC HORMONES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 71. INDONESIA SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 72. INDONESIA SYNTHETIC HORMONES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 73. JAPAN SYNTHETIC HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 74. JAPAN SYNTHETIC HORMONES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 75. JAPAN SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 76. JAPAN SYNTHETIC HORMONES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 77. MALAYSIA SYNTHETIC HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 78. MALAYSIA SYNTHETIC HORMONES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 79. MALAYSIA SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 80. MALAYSIA SYNTHETIC HORMONES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 81. PHILIPPINES SYNTHETIC HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 82. PHILIPPINES SYNTHETIC HORMONES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 83. PHILIPPINES SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 84. PHILIPPINES SYNTHETIC HORMONES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 85. SINGAPORE SYNTHETIC HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 86. SINGAPORE SYNTHETIC HORMONES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 87. SINGAPORE SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. SINGAPORE SYNTHETIC HORMONES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 89. SOUTH KOREA SYNTHETIC HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 90. SOUTH KOREA SYNTHETIC HORMONES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 91. SOUTH KOREA SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 92. SOUTH KOREA SYNTHETIC HORMONES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 93. TAIWAN SYNTHETIC HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 94. TAIWAN SYNTHETIC HORMONES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 95. TAIWAN SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 96. TAIWAN SYNTHETIC HORMONES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 97. THAILAND SYNTHETIC HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 98. THAILAND SYNTHETIC HORMONES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 99. THAILAND SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 100. THAILAND SYNTHETIC HORMONES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 101. VIETNAM SYNTHETIC HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 102. VIETNAM SYNTHETIC HORMONES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 103. VIETNAM SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 104. VIETNAM SYNTHETIC HORMONES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 105. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 106. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC HORMONES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 107. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 108. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC HORMONES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 109. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC HORMONES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 110. DENMARK SYNTHETIC HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 111. DENMARK SYNTHETIC HORMONES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 112. DENMARK SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 113. DENMARK SYNTHETIC HORMONES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 114. EGYPT SYNTHETIC HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 115. EGYPT SYNTHETIC HORMONES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 116. EGYPT SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 117. EGYPT SYNTHETIC HORMONES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 118. FINLAND SYNTHETIC HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 119. FINLAND SYNTHETIC HORMONES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 120. FINLAND SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 121. FINLAND SYNTHETIC HORMONES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 122. FRANCE SYNTHETIC HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 123. FRANCE SYNTHETIC HORMONES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 124. FRANCE SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 125. FRANCE SYNTHETIC HORMONES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 126. GERMANY SYNTHETIC HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 127. GERMANY SYNTHETIC HORMONES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 128. GERMANY SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 129. GERMANY SYNTHETIC HORMONES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 130. ISRAEL SYNTHETIC HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 131. ISRAEL SYNTHETIC HORMONES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 132. ISRAEL SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 133. ISRAEL SYNTHETIC HORMONES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 134. ITALY SYNTHETIC HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 135. ITALY SYNTHETIC HORMONES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 136. ITALY SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 137. ITALY SYNTHETIC HORMONES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 138. NETHERLANDS SYNTHETIC HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 139. NETHERLANDS SYNTHETIC HORMONES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 140. NETHERLANDS SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 141. NETHERLANDS SYNTHETIC HORMONES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 142. NIGERIA SYNTHETIC HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 143. NIGERIA SYNTHETIC HORMONES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 144. NIGERIA SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 145. NIGERIA SYNTHETIC HORMONES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 146. NORWAY SYNTHETIC HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 147. NORWAY SYNTHETIC HORMONES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 148. NORWAY SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 149. NORWAY SYNTHETIC HORMONES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 150. POLAND SYNTHETIC HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 151. POLAND SYNTHETIC HORMONES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 152. POLAND SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 153. POLAND SYNTHETIC HORMONES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 154. QATAR SYNTHETIC HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 155. QATAR SYNTHETIC HORMONES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 156. QATAR SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 157. QATAR SYNTHETIC HORMONES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 158. RUSSIA SYNTHETIC HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 159. RUSSIA SYNTHETIC HORMONES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 160. RUSSIA SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 161. RUSSIA SYNTHETIC HORMONES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 162. SAUDI ARABIA SYNTHETIC HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 163. SAUDI ARABIA SYNTHETIC HORMONES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 164. SAUDI ARABIA SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 165. SAUDI ARABIA SYNTHETIC HORMONES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 166. SOUTH AFRICA SYNTHETIC HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 167. SOUTH AFRICA SYNTHETIC HORMONES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 168. SOUTH AFRICA SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 169. SOUTH AFRICA SYNTHETIC HORMONES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 170. SPAIN SYNTHETIC HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 171. SPAIN SYNTHETIC HORMONES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 172. SPAIN SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 173. SPAIN SYNTHETIC HORMONES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 174. SWEDEN SYNTHETIC HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 175. SWEDEN SYNTHETIC HORMONES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 176. SWEDEN SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 177. SWEDEN SYNTHETIC HORMONES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 178. SWITZERLAND SYNTHETIC HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 179. SWITZERLAND SYNTHETIC HORMONES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 180. SWITZERLAND SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 181. SWITZERLAND SYNTHETIC HORMONES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 182. TURKEY SYNTHETIC HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 183. TURKEY SYNTHETIC HORMONES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 184. TURKEY SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 185. TURKEY SYNTHETIC HORMONES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 186. UNITED ARAB EMIRATES SYNTHETIC HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 187. UNITED ARAB EMIRATES SYNTHETIC HORMONES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 188. UNITED ARAB EMIRATES SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 189. UNITED ARAB EMIRATES SYNTHETIC HORMONES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 190. UNITED KINGDOM SYNTHETIC HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 191. UNITED KINGDOM SYNTHETIC HORMONES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 192. UNITED KINGDOM SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 193. UNITED KINGDOM SYNTHETIC HORMONES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 194. SYNTHETIC HORMONES MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 195. SYNTHETIC HORMONES MARKET, FPNV POSITIONING MATRIX, 2023

The Synthetic Hormones Market was valued at USD 899.20 million in 2023, expected to reach USD 1,024.43 million in 2024, and is projected to grow at a CAGR of 14.41%, to USD 2,307.77 million by 2030.

Synthetic hormones are artificially created hormones used in various applications, primarily in the medical and agricultural fields. These hormones are designed to mimic natural hormones and are key in treating hormone-related deficiencies and disorders. The necessity for synthetic hormones arises from the need to manage and treat conditions like hormonal imbalances, menopause symptoms, contraceptive needs, and growth disorders. In agriculture, they are crucial for enhancing livestock growth rates and productivity. The primary applications encompass pharmaceuticals, where they constitute essential components in hormonal treatments and birth control, and veterinary medicine. End-use scope primarily involves healthcare facilities, pharmaceutical companies, and agricultural sectors.

The market for synthetic hormones is driven by increasing awareness of hormonal disorders, advancements in biotechnology, and a growing aging population requiring hormonal therapies. Rising demand for personal wellness and preventive care further boosts market growth. Emerging opportunities exist in developing bioidentical hormones and exploring new delivery systems, such as transdermal patches and implantable devices, which promise enhanced patient compliance and efficacy. Additionally, personalized medicine offers prospects for tailoring hormone treatments to individual patient needs.

However, the market faces limitations such as regulatory hurdles, ethical concerns related to their use, and potential side effects, which can restrain growth. Moreover, public mistrust in synthetic drugs, coupled with increasing preference for natural alternatives, presents significant challenges. Market players need to prioritize transparency in clinical studies and safety to address consumer concerns.

To capitalize on market potentials, emphasis should be placed on R&D to innovate safer and more effective delivery methods and the development of sustainable and ethical production processes. Further research into expanding their use in novel therapeutic areas can open new avenues for growth. Understanding the nuanced regulatory landscapes across regions will also prove beneficial. The nature of the synthetic hormones market is dynamic, adapting constantly to technological advances and changing consumer preferences, demanding constant vigilance for emerging trends.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Synthetic Hormones Market

The Synthetic Hormones Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Surge in the incidence of hormonal imbalance in the population
  • Rise in prevalence of thyroid-related diseases and increase in health care expenditure
  • Rapid rise in the awareness among consumers about bioidentical hormones
• Market Restraints
  • High cost involved in hormonal replacement therapy
• Market Opportunities
  • Increase in research & development of new products by manufacturers
  • Rising incidence of irregular menstrual cycles
• Market Challenges
  • Certain side-effects related to hormones

Porter's Five Forces: A Strategic Tool for Navigating the Synthetic Hormones Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Synthetic Hormones Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Synthetic Hormones Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Synthetic Hormones Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Synthetic Hormones Market

A detailed market share analysis in the Synthetic Hormones Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Synthetic Hormones Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Synthetic Hormones Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Synthetic Hormones Market

A strategic analysis of the Synthetic Hormones Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Synthetic Hormones Market, highlighting leading vendors and their innovative profiles. These include American Regent, Inc. by Daiichi Sankyo Group Company, BIOTE MEDICAL, LLC., CSBio, Endo Pharmaceuticals Inc., Ferring International Center S.A., Lyndra Therapeutics, Pfizer Inc., and Slayback Pharma LLC.

Market Segmentation & Coverage

This research report categorizes the Synthetic Hormones Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Amino Acid Derivatives, Peptide Hormone, and Steroid Hormones.
• Based on Route of Administration, market is studied across Intravenous, Nasal, Oral, Suppository, and Topical.
• Based on Application, market is studied across Growth Hormone Deficiency, Male Hypogonadism, Menopause, and Thyroid Hormone Deficiency.
• Based on End-User, market is studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Surge in the incidence of hormonal imbalance in the population
    • 5.1.1.2. Rise in prevalence of thyroid-related diseases and increase in health care expenditure
    • 5.1.1.3. Rapid rise in the awareness among consumers about bioidentical hormones
  • 5.1.2. Restraints
    • 5.1.2.1. High cost involved in hormonal replacement therapy
  • 5.1.3. Opportunities
    • 5.1.3.1. Increase in research & development of new products by manufacturers
    • 5.1.3.2. Rising incidence of irregular menstrual cycles
  • 5.1.4. Challenges
    • 5.1.4.1. Certain side-effects related to hormones
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Synthetic Hormones Market, by Product

• 6.1. Introduction
• 6.2. Amino Acid Derivatives
• 6.3. Peptide Hormone
• 6.4. Steroid Hormones

7. Synthetic Hormones Market, by Route of Administration

• 7.1. Introduction
• 7.2. Intravenous
• 7.3. Nasal
• 7.4. Oral
• 7.5. Suppository
• 7.6. Topical

8. Synthetic Hormones Market, by Application

• 8.1. Introduction
• 8.2. Growth Hormone Deficiency
• 8.3. Male Hypogonadism
• 8.4. Menopause
• 8.5. Thyroid Hormone Deficiency

9. Synthetic Hormones Market, by End-User

• 9.1. Introduction
• 9.2. Hospital Pharmacies
• 9.3. Online Pharmacies
• 9.4. Retail Pharmacies

10. Americas Synthetic Hormones Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Synthetic Hormones Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Synthetic Hormones Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. American Regent, Inc. by Daiichi Sankyo Group Company
• 2. BIOTE MEDICAL, LLC.
• 3. CSBio
• 4. Endo Pharmaceuticals Inc.
• 5. Ferring International Center S.A.
• 6. Lyndra Therapeutics
• 7. Pfizer Inc.
• 8. Slayback Pharma LLC